Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3120ae9cab5bb4831f0cc16288966367 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 |
filingDate |
2004-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_decbee2d4e65546897bab66381a51ce6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc15a064e771f7471d578a866fb8d005 |
publicationDate |
2006-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1633390-A2 |
titleOfInvention |
Stabilized pharmaceutical peptide compositions |
abstract |
Method for increasing the shelf-life of a pharmaceutical composition for parenteral administration comprising a glucagon-like peptide which is prepared from a peptide product that has been subjected to treatment at a pH above neutral pH. |
priorityDate |
2003-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |